Please wait a minute...

中国生物工程杂志

China Biotechnology
China Biotechnology  2021, Vol. 41 Issue (4): 100-105    DOI: 10.13523/j.cb.2012019
    
Bio-tech Startup Incubation Best Practice in the United Kingdom and Suggestion
HU Yuan-lei1,CHEN Yan-cheng2,*(),PU Run3,*(),YAO Wei-hao4,ZHANG Hong-xiang5,6
1 School of Life Sciences,Peking University, Beijing 100871,China
2 Ministry of Science and Technology, Beijing 100862,China
3 China National Center for Biotechnology Development, Beijing 100039,China
4 Office of Science and Technology Development, Institute of Industrial Technology Research, Peking University,Beijing 100871,China
5 National Science Library, Chinese Academy of Science, Beijing 100190,China
6 Chinese Society of Biotechnology, Beijing 100101,China
Download: HTML   PDF(490KB) HTML
Export: BibTeX | EndNote (RIS)      

Abstract  

All major economies of the world have adopted biopharmaceutical industry as a strategic sector to prioritise. Biopharmaceutical industry has gradually become the new growth engine for the global economy. The United Kingdom ranks No.1 in Europe by the size of its biopharmaceutical industry. This article elaborates the role played by its local ecosystem in fostering the growth of the UK’s biopharmaceutical industry. We hope this article can serve as a reference for those who are involved in the innovation and venture building in China’s biopharmaceutical industry.



Key wordsBiotechnology      Innovation and startup ecosystem      Biotech incubator     
Received: 11 December 2020      Published: 30 April 2021
ZTFLH:  Q819  
Corresponding Authors: Yan-cheng CHEN,Run PU     E-mail: chenyc@most.gov.cn;purun@cncbd.org.cn
Cite this article:

HU Yuan-lei,CHEN Yan-cheng,PU Run,YAO Wei-hao,ZHANG Hong-xiang. Bio-tech Startup Incubation Best Practice in the United Kingdom and Suggestion. China Biotechnology, 2021, 41(4): 100-105.

URL:

https://manu60.magtech.com.cn/biotech/10.13523/j.cb.2012019     OR     https://manu60.magtech.com.cn/biotech/Y2021/V41/I4/100

[1]   封雪韵. 创新创业生态系统构成及其相互关系分析. 商业经济研究, 2017(4):124-126.
[1]   Feng X Y. Analysis on the composition of innovation and entrepreneurship ecosystem and its relationship. Journal of Commercial Economics, 2017(4):124-126.
[2]   常婷婷, 王秋实. 创新创业生态系统的运行机理研究. 信息通信技术与政策, 2019(3):7-9.
[2]   Chang T T, Wang Q S. Research on the operation mechanism of innovation and entrepreneurship ecosystem. Information and Communications Technology and Policy, 2019(3):7-9.
[3]   Gann D, Tackett M, Thorne C. Pathway to societal impact, a review of imperial college’s technology transfer, translation and related activities. London: Imperial College London, 2016: 19-21.
[4]   张柳燕, 常素华, 王晶. 从首个合成细胞看合成生物学的现状与发展. 科学通报, 2010,55(36):3477-3488.
[4]   Zhang L Y, Chang S H, Wang J. Current situation and development of synthetic biology from the perspective of the first synthetic cell. Chinese Science Bulletin, 2010,55(36):3477-3488.
[5]   UK Synthetic Biology Roadmap Coordination Group. A synthetic biology roadmap for the UK. London: Technology Strategy Board on behalf of UK Synthetic Biology Roadma, 2012: 4-5.
[6]   Clarke L J, Kitney R I. Synthetic biology in the UK - an outline of plans and progress. Synthetic and Systems Biotechnology, 2016,1(4):243-257.
pmid: 29062950
[7]   张大璐. 英国生物技术成果转化经验及若干启示. 中国生物工程杂志, 2012,32(9):131-134.
[7]   Zhang D L. Experience of British biotechnology achievements transformation and suggestions. China Biotechnology, 2012,32(9):131-134.
[8]   濮润, 董丽娟, 唐尚锋, 等. 我国区域生物医药产业分工研究. 医药导报, 2019,38(10):1376-1378.
[8]   Pu R, Dong L J, Tang S F, et al. Research on division of labor of regional biomedical industry in China. Herald of Medicine, 2019,38(10):1376-1378.
[9]   尹政清, 白京羽, 林晓锋. 我国各区域生物产业竞争力评价及实证分析. 生物工程学报, 2020,36(10):2216-2225.
[9]   Yin Z Q, Bai J Y, Lin X F. Assessment and empirical analysis of the competitiveness of bioindustry in various regions of China. Chinese Journal of Biotechnology, 2020,36(10):2216-2225.
[10]   敖翼, 濮润, 展勇, 等. 我国新药创制的发展现状及问题浅析. 中国新药杂志, 2020,29(1):33-41.
[10]   Ao Y, Pu R, Zhan Y, et al. Analysis on the status quo and problems of the development of new drugs in China. Chinese Journal of New Drugs, 2020,29(1):33-41.
[11]   白京羽, 林晓锋, 丁俊琦. 我国生物产业发展现状及政策建议. 中国科学院院刊, 2020,35(8):1053-1060.
[11]   Bai J Y, Lin X F, Ding J Q. Development status and policy suggestions of China’s biological industry. Bulletin of Chinese Academy of Sciences, 2020,35(8):1053-1060.
[12]   林毅夫, 张军, 王勇, 等. 产业政策: 总结、反思与展望. 北京: 北京大学出版社, 2018: 33.
[12]   Lin Y F, Zhang J, Wang Y, et al. Industrial policy: summary, reflection and prospect. Beijing: Peking University Press, 2018: 33.
[1] LIU Xu-xia,YANG An-ke. An Analysis of the U.S. SECURE Rule and Its Enlightenment to China[J]. China Biotechnology, 2021, 41(9): 126-135.
[2] WU Han-rong,WANG Ying,HUANG Ying-ming,LI Dong-xue,LI Zhi-fei,FANG Zi-han,FAN Lin. Promote the Innovation and Transformation of Biotechnology by Base Platform[J]. China Biotechnology, 2021, 41(12): 141-147.
[3] WU Han-rong,WANG Ying,YANG Li,GE Yao,FAN Ling. Current Situation and Development Suggestions of China’s Biotechnology Base Platform[J]. China Biotechnology, 2021, 41(11): 119-123.
[4] WU Han-rong,WANG Ying,LI Su-ning,SANG Xiao-dong,FAN Ling. Policy Research on the Construction of Biotechnology Base Platforms in China[J]. China Biotechnology, 2021, 41(10): 127-131.
[5] WANG Xiao-li. The Age of Biosecurity: New Biotechnology Revolution and National Biosecurity Governance[J]. China Biotechnology, 2020, 40(9): 95-109.
[6] SONG Yi-mei,JIA Xiu-wei,LI Shu-biao,GAO Cui-juan. Industrial Microorganism of Yarrowia lipolytica and Its Industrial Amplicaiton[J]. China Biotechnology, 2020, 40(9): 77-86.
[7] HU Yuan-lei,YAO Wei-hao,PU Run,ZHANG Hong-xiang. Bio-tech Startup Incubation Best Practice in the United States[J]. China Biotechnology, 2019, 39(12): 103-109.
[8] Ping ZHAO,Bo ZHANG,Xue-zhao WANG. Patent Situation Analysis in Agricultural Biotechnology Field[J]. China Biotechnology, 2018, 38(8): 100-107.
[9] Fang CHEN,Yun-wei CHEN,Chen-jun DING,Ying ZHENG,Xiao-yan WU,Dan-dan LUO,Qiu-wei ZHAO,Bo YU. A Study on the Trends of Biotechnology Development in Countries along the Belt and Road[J]. China Biotechnology, 2018, 38(1): 1-14.
[10] SHEN Ping, WU Yu-hua, LIANG Jin-gang, LU Xin, ZHANG Qiu-yan, WANG Hao-qian, LIU Peng-cheng. The Overview in Development and Application of Genetically Modifed Crops[J]. China Biotechnology, 2017, 37(1): 119-128.
[11] CHEN Fang, DING Chen-jun, CHEN Yun-wei, ZHENG Ying, DENG Yong, XU Ping, YU Jian-rong, WU Lin-huan, MA Jun-cai, ZENG Yan, LIU Bin. A Study on the Trend and Prospective of Industrial Biotechnology in China[J]. China Biotechnology, 2016, 36(5): 1-11.
[12] LI Geng, LIU Xiao-zhi, WANG Zhi-ming, GAO Jian. Progress in the Application of Non-immunoglobulin Scaffolds[J]. China Biotechnology, 2016, 36(2): 90-95.
[13] WANG Kai, ZHANG Wei, LI Shi-weng. Study and Application of Phytase[J]. China Biotechnology, 2015, 35(9): 85-93.
[14] GAO Jiao-qi, HAN Xi-tong, KONG Liang, YUAN Wen-jie, WANG Na, BAI Feng-wu. Application Progress of Kluyveromyces marxianus in the Industrial Biotechnology[J]. China Biotechnology, 2014, 34(2): 109-117.
[15] WU Xue-mei, QU Kai. Problems and Solutions in the Drafting of Biotechnological Patents[J]. China Biotechnology, 2013, 33(12): 127-132.